title: Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs.
abstract: The role of vascular endothelium in cardiovascular disorders is well recognized. Mature endothelial cells contribute to the repair of endothelial injury, but they only have a limited capacity to do so. This has led to growing interest and further investigation into circulating endothelial progenitor cells (EPCs) and their role in vascular healing, repair, and postnatal neovascularization. The current perception of vascular health is that of a balance between ongoing injury and resultant vascular repair, mediated at least in part by circulating EPCs. Circulating EPCs play an important role in accelerating endothelialization at areas of vascular damage, and EPC enumeration is a viable strategy for assessing reparative capacity. Recent studies have shown that EPCs are affected both in number and function by several cardiovascular risk factors as well as various cardiovascular disease states, such as hypertension, hypercholesterolemia, and coronary artery disease. The present review summarizes the most relevant studies on the effects of cardiovascular drugs on vascular function and EPCs, focusing on their mechanisms of action.
authors.affiliation: Cardiology Department, Coimbra University Hospital and Medical School, Coimbra, Portugal. natalia.antonio@gmail.com
authors.forename: Natália
authors.initials: N
authors.lastname: António
authors.forename: Rosa
authors.initials: R
authors.lastname: Fernandes
authors.forename: Noela
authors.initials: N
authors.lastname: Rodriguez-Losada
authors.forename: Manuel F
authors.initials: MF
authors.lastname: Jiménez-Navarro
authors.forename: Artur
authors.initials: A
authors.lastname: Paiva
authors.forename: Eduardo
authors.initials: E
authors.lastname: de Teresa Galván
authors.forename: Lino
authors.initials: L
authors.lastname: Gonçalves
authors.forename: Carlos Fontes
authors.initials: CF
authors.lastname: Ribeiro
authors.forename: Luís A
authors.initials: LA
authors.lastname: Providência
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D000818:Animals; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D012038:Regeneration / Q000187:drug effects*; D013234:Stem Cells / Q000187:drug effects* / Q000473:pathology
chemical_list: D043925:Angiogenesis Inducing Agents; D002317:Cardiovascular Agents